BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9446643)

  • 1. Effects of cytokines on platelet production from blood and marrow CD34+ cells.
    Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N
    Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells.
    Debili N; Massé JM; Katz A; Guichard J; Breton-Gorius J; Vainchenker W
    Blood; 1993 Jul; 82(1):84-95. PubMed ID: 7686791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
    Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
    Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.
    Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM
    Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
    Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
    Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.
    Halle P; Rouzier C; Kanold J; Boiret N; Rapatel C; Mareynat G; Tchirkov A; Berger M; Travade P; Bonhomme J; Deméocq F
    Ann Hematol; 2000 Jan; 79(1):13-9. PubMed ID: 10663616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
    Haddad E; Cramer E; Rivière C; Rameau P; Louache F; Guichard J; Nelson DL; Fischer A; Vainchenker W; Debili N
    Blood; 1999 Jul; 94(2):509-18. PubMed ID: 10397718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
    Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
    Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.
    Cramer EM; Norol F; Guichard J; Breton-Gorius J; Vainchenker W; Massé JM; Debili N
    Blood; 1997 Apr; 89(7):2336-46. PubMed ID: 9116277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH; Olszewski M; Kletzel M
    J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes.
    van den Oudenrijn S; de Haas M; Calafat J; van der Schoot CE; von dem Borne AE
    Br J Haematol; 1999 Aug; 106(2):553-63. PubMed ID: 10460622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3.
    Dolzhanskiy A; Basch RS; Karpatkin S
    Blood; 1997 Jan; 89(2):426-34. PubMed ID: 9002944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB
    Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro expansion of CD34+/CD41+ cells from human peripheral blood CD34+/CD41- cells: role of cytokines for in vitro proliferation and differentiation of megakaryocytic progenitors.
    Koizumi K; Sawada K; Yamaguchi M; Notoya A; Tarumi T; Takano H; Fukada Y; Nishio M; Katagiri E; Yasukouchi T; Sato N; Sekiguchi S; Koike T
    Exp Hematol; 1998 Nov; 26(12):1140-7. PubMed ID: 9808053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytokines in sustaining long-term human megakaryocytopoiesis in vitro.
    Briddell RA; Brandt JE; Leemhuis TB; Hoffman R
    Blood; 1992 Jan; 79(2):332-7. PubMed ID: 1370383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.